Loading HSTA…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("HSTA","financials")Full statements spill as a table. For one cell: =jivedata("HSTA","Revenue") or =jivedata("HSTA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
HSTA • CIK 0001813603
| (in thousands, except per share data) | FY 2023 | FY 2023 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $1,249.884 | $113.413 | $8 | $24 |
| Operating Expenses | $398.355 | $415.061 | $312.919 | $656.413 |
| Operating Income (Loss) | $851.529 | $-301.648 | $-304.919 | $-632.413 |
| Other Nonoperating Income (Expense) | $-117.437 | $-198.757 | $-730.412 | $-730.412 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $734.092 | $-500.405 | $-1,035.331 | $-869.545 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $642.205 | $-500.405 | $-943.444 | $-943.444 |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 27,939,260 | 27,939,260 |
| Interest and Dividend Income, Operating | $1.125 | $3.676 | $0.075 | $0.075 |
| Interest Expense | $3.038 | — | $9.571 | $9.571 |
| Gain (Loss) on Sale of Capital Leases, Net | $-74.889 | $-74.889 | $-20.277 | $-20.277 |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | — | $6.66 | $0 |
| (in thousands, except per share data) | FY 2023 | FY 2023 | FY 2025 | TTM |
|---|---|---|---|---|
| Assets | $1,146.635 | $194.338 | $395.131 | $473.594 |
| Liabilities | $206.306 | $16.214 | $278.245 | $835.682 |
| Stockholders' Equity Attributable to Parent | $940.329 | $178.124 | $116.886 | $-362.088 |
| Assets, Current | $1,124.042 | $166.896 | $395.131 | $473.594 |
| Machinery and Equipment, Gross | $8.39 | $27.442 | $8.39 | $7.691 |
| Property, Plant and Equipment, Net | $22.593 | $27.442 | $22.593 | $7.691 |
| Common Stock, Value, Issued | $27.939 | $27.939 | $27.939 | $27.939 |
| Additional Paid in Capital | $1,021.613 | $901.613 | $1,141.613 | $1,141.613 |
| Retained Earnings (Accumulated Deficit) | $-114.323 | $-756.528 | $-1,057.766 | $-1,536.74 |
| Cash Equivalents, at Carrying Value | $41.163 | $93.89 | $28.871 | $28.871 |
| Investments | $1,068.219 | $73.006 | $366.26 | $454.453 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $14.66 | — | $14.66 | $8 |
| Accounts Payable and Accrued Liabilities, Current | $32.45 | $16.214 | $76.08 | $67.998 |
| Notes Payable, Current | — | — | $17.5 | $17.5 |
| Common Stock, Shares Authorized | 285,000,000 | 285,000,000 | 285,000,000 | 285,000,000 |
| Common Stock, Shares, Issued | 27,939,260 | 27,939,260 | 27,939,260 | 27,939,260 |
| (in thousands, except per share data) | FY 2023 | FY 2023 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $642.205 | $-500.405 | $-943.444 | $-777.658 |
| Net Cash Provided by (Used in) Operating Activities | $-168.805 | $-278.214 | $-134.272 | $-138.496 |
| Net Cash Provided by (Used in) Investing Activities | $37.147 | $119.148 | $9.48 | $1.635 |
| Net Cash Provided by (Used in) Financing Activities | $78.931 | $26.195 | $112.5 | $121.67 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $-52.727 | $-159.066 | $-12.292 | $-15.191 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $41.163 | $93.89 | $28.871 | $7.996 |
| Notes Assumed | — | — | $1,147.884 | $1,147.884 |
| Depreciation | $4.849 | $13.233 | $0.816 | $0.116 |
| Share-based Payment Arrangement, Noncash Expense | $120 | — | $120 | $0 |
| Debt Securities, Available-for-sale, Realized Loss | $74.889 | $74.889 | $20.277 | $20.277 |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | — | $6.66 | $0 |
| Deferred Income Tax Expense (Benefit) | — | — | $-91.887 | $-91.887 |
| Proceeds from Sale of Productive Assets | $46 | $46 | $1.5 | $1.5 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $16.236 | $6.525 | $51.327 | $3.678 |
| Payments to Acquire Equity Method Investments | $16.198 | $30.125 | $16.198 | $16.198 |
| Increase (Decrease) in Accrued Interest Receivable, Net | $-3.038 | — | $-3.038 | $-3.038 |
| Proceeds from Sale of Equity Method Investments | $53.345 | $103.658 | $7.98 | $0.135 |
| Proceeds from Loans | — | — | $17.5 | $17.5 |
| Proceeds from Issuance of Common Stock | $78.931 | $26.195 | $95 | $95 |